JP40:F:F-Amundi Index Solutions - Amundi JPX-Nikkei 400 (EUR)

ETF | Others |

Last Closing

USD 184.38

Change

+3.40 (+1.88)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

-5.14 (-0.94%)

USD 108.00B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.15 (+0.29%)

USD 105.67B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.07 (+0.13%)

USD 104.83B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.01 (+0.08%)

USD 62.86B
VUSA:F Vanguard Funds Public Limited ..

-0.57 (-0.59%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.65 (-0.28%)

USD 49.04B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 41.48B
0ZC:F Zscaler Inc

-2.56 (-1.41%)

USD 37.92B
BSND:F Danone SA

-0.20 (-1.45%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

+0.32 (+0.26%)

USD 24.77B

ETFs Containing JP40:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.96% 56% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.96% 55% F 56% F
Trailing 12 Months  
Capital Gain 4.09% 51% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.09% 49% F 49% F
Trailing 5 Years  
Capital Gain 74.24% 56% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 74.24% 56% F 44% F
Average Annual (5 Year Horizon)  
Capital Gain 8.51% 62% D 61% D-
Dividend Return 8.51% 59% D- 53% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.57% 60% D- 88% B+
Risk Adjusted Return 73.56% 73% C 80% B-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike